New Multiple Myeloma Staging Systems Outperform the Standard

Findings from a large US cohort study show comparable accuracy, but better discrimination of patients across disease stages.

Related Keywords

United States ,Salt Lake City ,Utah ,University Of Utah ,American ,Manni Mohyuddin ,Flatiron Health ,Huntsman Cancer Institute ,American Society Of Hematology ,International Staging System ,American Society ,Revised International Staging System ,Second Revision ,Mayo Additive Staging System ,Salt Lake ,Medscape Medical ,Multiple Myeloma ,Myeloma ,Plasma Cell Myeloma ,Cancer ,Alignant Neoplasia ,Arcinoma ,Alignant Neoplasm ,Alabama ,Clinical Research ,Clinical Trials ,Linical Studies ,Pre Clinical Trial ,Double Blind Study ,Double Blind Studies ,Ingle Blind Study ,Ingle Blind Studies ,Electronic Medical Record ,Mr ,Electronic Health Record ,Hr ,Omputerized Medical Records Systems ,